{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:12:02Z","timestamp":1789596722681,"version":"build-2803163510"},"reference-count":380,"publisher":"The Endocrine Society","issue":"1","license":[{"start":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:00:00Z","timestamp":1515110400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HD083026"],"award-info":[{"award-number":["R01HD083026"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN 126019"],"award-info":[{"award-number":["FRN 126019"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN 93615"],"award-info":[{"award-number":["FRN 93615"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FRN 138657"],"award-info":[{"award-number":["FRN 138657"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1210\/er.2017-00103","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T21:35:19Z","timestamp":1515101719000},"page":"36-78","source":"Crossref","is-referenced-by-count":112,"title":["Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms"],"prefix":"10.1210","volume":"39","author":[{"given":"Janet P","family":"Hapgood","sequence":"first","affiliation":[{"name":"Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa"},{"name":"Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Kaushic","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Medicine, McMaster University, Ontario, Canada"},{"name":"McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Hel","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama"},{"name":"Center for AIDS Research, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,1,4]]},"reference":[{"issue":"10041","key":"2019041121595831000_B1","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(16)30380-4","article-title":"Abortion incidence between 1990 and 2014: global, regional, and subregional levels and trends","volume":"388","author":"Sedgh","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"2019041121595831000_B2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1728-4465.2014.00393.x","article-title":"Intended and unintended pregnancies worldwide in 2012 and recent trends","volume":"45","author":"Sedgh","year":"2014","journal-title":"Stud Fam Plann"},{"key":"2019041121595831000_B3","unstructured":"United Nations Department of Economic and Social Affairs Population Division. Trends in contraceptive use worldwide 2015. Available at: http:\/\/www.un.org\/en\/development\/desa\/population\/publications\/pdf\/family\/trendsContraceptiveUse2015Report.pdf. Accessed on 31 December 2017."},{"issue":"17","key":"2019041121595831000_B4","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1097\/QAD.0000000000001228","article-title":"An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women","volume":"30","author":"Polis","year":"2016","journal-title":"AIDS"},{"issue":"1","key":"2019041121595831000_B5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1210\/er.2009-0018","article-title":"Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection","volume":"31","author":"Hel","year":"2010","journal-title":"Endocr Rev"},{"issue":"2","key":"2019041121595831000_B6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/aji.12209","article-title":"Research gaps in defining the biological link between HIV risk and hormonal contraception","volume":"72","author":"Murphy","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"2019041121595831000_B7","unstructured":"Lipsitz R . Women in India get a new birth control option. Available at: http:\/\/www.ourbodiesourselves.org\/2016\/03\/women-in-india-get-a-new-birth-control-option\/. Accessed on 31 December 2017."},{"issue":"6","key":"2019041121595831000_B8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/GCO.0000000000000329","article-title":"Injectable contraception: updates and innovation","volume":"28","author":"Schivone","year":"2016","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2019041121595831000_B9","unstructured":"Pfizer. Novel agreement expands access to Pfizer\u2019s contraceptive, Sayana\u00ae Press, for women most in need in the world\u2019s poorest countries. Available at: http:\/\/www.familyplanning2020.org\/articles\/4458. Accessed on 31 December 2017."},{"key":"2019041121595831000_B10","unstructured":"Whipkey K , DrakeJ, KadeK, BalderstonB. Advocacy pack for subcutaneous DMPA. Available at: https:\/\/www.rhsupplies.org\/activities-resources\/tools\/advocacy-pack-for-subcutaneous-dmpa\/. Accessed on 31 December 2017."},{"key":"2019041121595831000_B11","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). Fact sheet 2016. Available at: http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/20150901_FactSheet_2015_en.pdf. Accessed 30 December 2017."},{"issue":"8","key":"2019041121595831000_B12","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/S2352-3018(16)30087-X","article-title":"Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: the Global Burden of Disease Study 2015","volume":"3","author":"GBD 2015 HIV Collaborators","year":"2016","journal-title":"Lancet HIV"},{"key":"2019041121595831000_B13","unstructured":"Avert. HIV around the world. Available at: http:\/\/www.avert.org\/professionals\/hiv-around-world. Accessed 30 December 2017."},{"key":"2019041121595831000_B14","unstructured":"UNAIDS. South Africa: HIV and AIDS estimates. Available at: http:\/\/www.unaids.org\/en\/regionscountries\/countries\/southafrica. Accessed 30 December 2017."},{"issue":"1","key":"2019041121595831000_B15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/QAD.0b013e32835a5a52","article-title":"Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk","volume":"27","author":"Butler","year":"2013","journal-title":"AIDS"},{"issue":"1","key":"2019041121595831000_B16","doi-asserted-by":"crossref","first-page":"e1001778","DOI":"10.1371\/journal.pmed.1001778","article-title":"Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis","volume":"12","author":"Morrison","year":"2015","journal-title":"PLoS Med"},{"issue":"6","key":"2019041121595831000_B17","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/GCO.0000000000000228","article-title":"Hormonal contraceptive use and women\u2019s risk of HIV acquisition: priorities emerging from recent data","volume":"27","author":"Ralph","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"7","key":"2019041121595831000_B18","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/S2352-3018(15)00058-2","article-title":"Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study","volume":"2","author":"Noguchi","year":"2015","journal-title":"Lancet HIV"},{"issue":"7","key":"2019041121595831000_B19","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s10461-016-1563-y","article-title":"Objective measurement of inaccurate condom use reporting among women using depot medroxyprogesterone acetate for contraception","volume":"21","author":"Heffron","year":"2017","journal-title":"AIDS Behav"},{"issue":"4","key":"2019041121595831000_B20","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.contraception.2016.12.003","article-title":"Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk","volume":"95","author":"Smith","year":"2017","journal-title":"Contraception"},{"issue":"12","key":"2019041121595831000_B21","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s10461-014-0741-z","article-title":"Are hormonal contraceptive users more likely to misreport unprotected sex? Evidence from a biomarker validation study in Zimbabwe","volume":"18","author":"McCoy","year":"2014","journal-title":"AIDS Behav"},{"key":"2019041121595831000_B22","unstructured":"World Health Organization. Can women who are at high risk of acquiring HIV, safely use hormonal contraception? Available at: http:\/\/www.who.int\/reproductivehealth\/topics\/family_planning\/hormonal-contraception-hiv\/en\/. Accessed 30 December 2017."},{"key":"2019041121595831000_B23","unstructured":"ECHO. The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study. Available at: http:\/\/echo-consortium.com\/. Accessed 30 December 2017."},{"issue":"2","key":"2019041121595831000_B24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr Rev"},{"issue":"7","key":"2019041121595831000_B25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.steroids.2011.03.001","article-title":"Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception","volume":"76","author":"Africander","year":"2011","journal-title":"Steroids"},{"key":"2019041121595831000_B26","doi-asserted-by":"crossref","unstructured":"Draper BH , MorroniC, HoffmanM, SmitJ, BeksinskaM, HapgoodJ, Van der MerweL. Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception. Cochrane Database Syst Rev. 2006; (3):CD005214.","DOI":"10.1002\/14651858.CD005214.pub2"},{"issue":"3","key":"2019041121595831000_B27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.contraception.2012.08.002","article-title":"Contraception technology: past, present and future","volume":"87","author":"Sitruk-Ware","year":"2013","journal-title":"Contraception"},{"issue":"6","key":"2019041121595831000_B28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.bpobgyn.2014.05.003","article-title":"Progestin-only contraception: injectables and implants","volume":"28","author":"Jacobstein","year":"2014","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"2019041121595831000_B29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.contraception.2016.02.003","article-title":"The safety of subcutaneously administered depot medroxyprogesterone acetate (104 mg\/0.65 mL): a systematic review","volume":"94","author":"Dragoman","year":"2016","journal-title":"Contraception"},{"key":"2019041121595831000_B30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/13697137.2013.802556","article-title":"Progesterone and related progestins: potential new health benefits","volume":"16","author":"Sitruk-Ware","year":"2013","journal-title":"Climacteric"},{"issue":"11","key":"2019041121595831000_B31","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.tips.2004.09.005","article-title":"Not all progestins are the same: implications for usage","volume":"25","author":"Hapgood","year":"2004","journal-title":"Trends Pharmacol Sci"},{"issue":"10\u201313","key":"2019041121595831000_B32","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.steroids.2003.08.003","article-title":"All progestins are not created equal","volume":"68","author":"Stanczyk","year":"2003","journal-title":"Steroids"},{"key":"2019041121595831000_B33","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/QAD.0000000000000036","article-title":"Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches","volume":"27","author":"Polis","year":"2013","journal-title":"AIDS"},{"issue":"3","key":"2019041121595831000_B34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/08923978209026438","article-title":"Effect of medroxyprogesterone acetate upon PHA, Con A and PWM stimulated lymphocytes and on E-rosette function","volume":"4","author":"Corsini","year":"1982\u20131983","journal-title":"J Immunopharmacol"},{"issue":"10","key":"2019041121595831000_B35","first-page":"699","article-title":"Effect of tamoxifen and high-dose medroxyprogesterone acetate (MPA) on cell-mediated immune functions in breast cancer patients","volume":"12","author":"Mallmann","year":"1990","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"18","key":"2019041121595831000_B36","doi-asserted-by":"crossref","first-page":"9845","DOI":"10.1128\/JVI.77.18.9845-9851.2003","article-title":"Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2","volume":"77","author":"Gillgrass","year":"2003","journal-title":"J Virol"},{"issue":"1","key":"2019041121595831000_B37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.virol.2006.04.004","article-title":"Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques","volume":"352","author":"Trunova","year":"2006","journal-title":"Virology"},{"issue":"1","key":"2019041121595831000_B38","first-page":"157","article-title":"Pharmacology of progestogens","volume":"8","author":"Kuhl","year":"2011","journal-title":"J Reproduktionsmed Endokrinol."},{"key":"2019041121595831000_B39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"issue":"2","key":"2019041121595831000_B40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.contraception.2016.03.010","article-title":"The elusive minimum threshold concentration of levonorgestrel for contraceptive efficacy","volume":"94","author":"Cherala","year":"2016","journal-title":"Contraception"},{"issue":"1","key":"2019041121595831000_B41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.contraception.2009.01.004","article-title":"Serum levonorgestrel levels and endometrial thickness during extended use of the levonorgestrel-releasing intrauterine system","volume":"80","author":"Hidalgo","year":"2009","journal-title":"Contraception"},{"issue":"6","key":"2019041121595831000_B42","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/FTD.0b013e31829a10fa","article-title":"A UPLC-MS\/MS method for therapeutic drug monitoring of etonogestrel","volume":"35","author":"Thomas","year":"2013","journal-title":"Ther Drug Monit"},{"issue":"2","key":"2019041121595831000_B43","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3797\/scipharm.1111-18","article-title":"Randomized, crossover and single-dose bioequivalence study of two oral desogestrel formulations (film-coated tablets of 75 \u03bcg) in healthy female volunteers","volume":"80","author":"Pena","year":"2012","journal-title":"Sci Pharm"},{"issue":"5","key":"2019041121595831000_B44","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0010-7824(87)90083-7","article-title":"Pharmacokinetics of norethisterone in humans","volume":"35","author":"Shi","year":"1987","journal-title":"Contraception"},{"issue":"1","key":"2019041121595831000_B45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.contraception.2003.09.005","article-title":"Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of the dosing interval","volume":"69","author":"Smit","year":"2004","journal-title":"Contraception"},{"key":"2019041121595831000_B46","unstructured":"U.S. Food and Drug Administration. Depo-SubQ Provera 104 (medroxyprogesterone acetate) injectable suspension. New drug application no. 021583. Center for Drug Evaluation and Research clinical pharmacology and biopharmaceutics review. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2005\/021584s000_depo-subQTOC.cfm. Accessed 31 December 2017."},{"issue":"8","key":"2019041121595831000_B47","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0022-4731(81)90015-7","article-title":"Medroxyprogesterone acetate in human serum","volume":"14","author":"Mathrubutham","year":"1981","journal-title":"J Steroid Biochem"},{"issue":"1","key":"2019041121595831000_B48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0010-7824(74)90130-9","article-title":"Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera)","volume":"10","author":"Kirton","year":"1974","journal-title":"Contraception"},{"issue":"4","key":"2019041121595831000_B49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0010-7824(76)80060-1","article-title":"Medroxyprogesterone acetate, estradiol, FSH and LH in peripheral blood after intramuscular administration of Depo-Provera to women","volume":"14","author":"Jeppsson","year":"1976","journal-title":"Contraception"},{"issue":"2","key":"2019041121595831000_B50","first-page":"57","article-title":"Injected long-acting medroxyprogesterone acetate. Effect on human lactation and concentrations in milk","volume":"60","author":"Koetsawang","year":"1977","journal-title":"J Med Assoc Thai"},{"issue":"4","key":"2019041121595831000_B51","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0022-4731(78)90631-3","article-title":"A radioimmunoassay for serum medroxyprogesterone acetate","volume":"9","author":"Shrimanker","year":"1978","journal-title":"J Steroid Biochem"},{"issue":"2","key":"2019041121595831000_B52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0015-0282(16)44895-8","article-title":"A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate","volume":"34","author":"Fotherby","year":"1980","journal-title":"Fertil Steril"},{"issue":"5","key":"2019041121595831000_B53","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0010-7824(80)90105-5","article-title":"Pharmacokinetic study of different doses of Depo Provera","volume":"22","author":"Fotherby","year":"1980","journal-title":"Contraception"},{"issue":"3","key":"2019041121595831000_B54","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/acta.0.0990339","article-title":"Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent","volume":"99","author":"Jeppsson","year":"1982","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041121595831000_B55","first-page":"157","article-title":"Concentration changes if medroxyprogesterone acetate in serum and milk in lactating women who used depo geston","volume":"15","author":"Fang","year":"2004","journal-title":"J Reprod Contraception."},{"issue":"5","key":"2019041121595831000_B56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.contraception.2014.01.017","article-title":"A pilot study of depot medroxyprogesterone acetate pharmacokinetics and weight gain in adolescent females","volume":"89","author":"Bonny","year":"2014","journal-title":"Contraception"},{"issue":"1","key":"2019041121595831000_B57","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.contraception.2016.03.003","article-title":"Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trial","volume":"94","author":"Nanda","year":"2016","journal-title":"Contraception"},{"issue":"1","key":"2019041121595831000_B58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jcem-44-1-32","article-title":"Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA","volume":"44","author":"Ortiz","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2019041121595831000_B59","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0010-7824(96)00170-9","article-title":"Pharmacodynamic effects of depot-medroxyprogesterone acetate (DMPA) administered to lactating women on their male infants","volume":"54","author":"Virutamasen","year":"1996","journal-title":"Contraception"},{"issue":"5","key":"2019041121595831000_B60","first-page":"381","article-title":"Pharmacokinetics of depot medroxyprogesterone acetate contraception","volume":"41","author":"Mishell","year":"1996","journal-title":"J Reprod Med"},{"issue":"1","key":"2019041121595831000_B61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.contraception.2009.02.005","article-title":"Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density","volume":"80","author":"Kaunitz","year":"2009","journal-title":"Contraception"},{"issue":"1","key":"2019041121595831000_B62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2004.01.011","article-title":"Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"issue":"11","key":"2019041121595831000_B63","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.clinthera.2004.11.013","article-title":"Suppression of ovulation by a new subcutaneous depot medroxyprogesterone acetate (104 mg\/0.65 mL) contraceptive formulation in Asian women","volume":"26","author":"Toh","year":"2004","journal-title":"Clin Ther"},{"issue":"1","key":"2019041121595831000_B64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.contraception.2013.07.002","article-title":"Pharmacokinetics of subcutaneous depot medroxyprogesterone acetate injected in the upper arm","volume":"89","author":"Halpern","year":"2014","journal-title":"Contraception"},{"issue":"4","key":"2019041121595831000_B65","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.contraception.2012.12.008","article-title":"Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS)","volume":"87","author":"Selim","year":"2013","journal-title":"Contraception"},{"issue":"2","key":"2019041121595831000_B66","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(96)00276-4","article-title":"Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants","volume":"55","author":"Sivin","year":"1997","journal-title":"Contraception"},{"issue":"1\u20132","key":"2019041121595831000_B67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jchromb.2006.12.052","article-title":"A semi-automated 96-well plate method for the simultaneous determination of oral contraceptives concentrations in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry","volume":"852","author":"Licea-Perez","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"1","key":"2019041121595831000_B68","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0010-7824(82)90171-8","article-title":"Metabolism of injectable formulations of contraceptive steroids in obese and thin women","volume":"26","author":"Fotherby","year":"1982","journal-title":"Contraception"},{"issue":"1","key":"2019041121595831000_B69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0010-7824(81)90065-2","article-title":"Pharmacokinetics of norethisterone oenanthate in humans","volume":"24","author":"Sang","year":"1981","journal-title":"Contraception"},{"issue":"3","key":"2019041121595831000_B70","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-7824(79)90022-2","article-title":"Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone","volume":"19","author":"Goebelsmann","year":"1979","journal-title":"Contraception"},{"issue":"5","key":"2019041121595831000_B71","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0010-7824(98)00110-3","article-title":"Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon","volume":"58","author":"Wenzl","year":"1998","journal-title":"Contraception"},{"issue":"2","key":"2019041121595831000_B72","doi-asserted-by":"crossref","first-page":"110.e1-6","DOI":"10.1016\/j.ajog.2012.05.002","article-title":"Pharmacokinetics of the etonogestrel contraceptive implant in obese women","volume":"207","author":"Mornar","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"2019041121595831000_B73","first-page":"1139","article-title":"Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulations","volume":"42","author":"Kuhnz","year":"1992","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"2019041121595831000_B74","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.fertnstert.2007.07.1348","article-title":"Pharmacokinetic interactions between depot medroxyprogesterone acetate and combination antiretroviral therapy","volume":"90","author":"Nanda","year":"2008","journal-title":"Fertil Steril"},{"issue":"9","key":"2019041121595831000_B75","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0277-5379(90)90624-3","article-title":"Comparison of mass spectrometry and radioimmunoassay to measure medroxyprogesterone acetate in patients with endometrial cancer","volume":"26","author":"K\u00e4rkk\u00e4inen","year":"1990","journal-title":"Eur J Cancer"},{"issue":"4","key":"2019041121595831000_B76","doi-asserted-by":"crossref","first-page":"e93805","DOI":"10.1371\/journal.pone.0093805","article-title":"Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry","volume":"9","author":"Keefe","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"2019041121595831000_B77","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0731-7085(89)80072-X","article-title":"A comparison of the high-performance liquid chromatography and RIA measurement of medroxyprogesterone acetate","volume":"7","author":"Mould","year":"1989","journal-title":"J Pharm Biomed Anal"},{"issue":"1","key":"2019041121595831000_B78","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/bjc.1988.165","article-title":"The pharmacokinetics of medroxyprogesterone acetate following two different loading dose schedules in advanced carcinoma of the breast","volume":"58","author":"Canney","year":"1988","journal-title":"Br J Cancer"},{"issue":"2","key":"2019041121595831000_B79","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF00417835","article-title":"Plasma concentrations of medroxyprogesterone acetate and megesterol acetate during long-term follow-up in patients treated for metastatic breast cancer","volume":"114","author":"Miller","year":"1988","journal-title":"J Cancer Res Clin Oncol"},{"issue":"11","key":"2019041121595831000_B80","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/1097-0142(19880601)61:11<2214::AID-CNCR2820611115>3.0.CO;2-V","article-title":"Effects of antiestrogen and progestin on immune functions in breast cancer patients","volume":"61","author":"Scambia","year":"1988","journal-title":"Cancer"},{"issue":"11","key":"2019041121595831000_B81","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2346::AID-CNCR12>3.0.CO;2-0","article-title":"Medroxyprogesterone acetate treatment reduces serum interleukin-6 levels in patients with metastatic breast carcinoma","volume":"78","author":"Yamashita","year":"1996","journal-title":"Cancer"},{"issue":"3","key":"2019041121595831000_B82","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF02111804","article-title":"Effect of medroxyprogesterone acetate on serum levels of LH, FSH, cortisol, and estrone in patients with endometrial carcinoma","volume":"230","author":"Vesterinen","year":"1981","journal-title":"Arch Gynecol"},{"issue":"2","key":"2019041121595831000_B83","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF00434347","article-title":"Lack of correlations between plasma concentration of medroxyprogesterone acetate, hypothalamic-pituitary function, and tumour response in patients with advanced breast cancer","volume":"14","author":"Hedley","year":"1985","journal-title":"Cancer Chemother Pharmacol"},{"issue":"17","key":"2019041121595831000_B84","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1097\/QAD.0000000000001229","article-title":"Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals","volume":"30","author":"Polis","year":"2016","journal-title":"AIDS"},{"issue":"6","key":"2019041121595831000_B85","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/aid.2015.0264","article-title":"Comparison of follicular and luteal phase mucosal markers of HIV susceptibility in healthy women","volume":"32","author":"Thurman","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"2019041121595831000_B86","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/mi.2013.46","article-title":"Ovarian steroid hormones: effects on immune responses and Chlamydia trachomatis infections of the female genital tract","volume":"6","author":"Hafner","year":"2013","journal-title":"Mucosal Immunol"},{"issue":"2","key":"2019041121595831000_B87","first-page":"100","article-title":"Reduced sensitivity to glucocorticoid feedback and reduced glucocorticoid receptor mRNA expression in the luteal phase of the menstrual cycle","volume":"17","author":"Altemus","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"2019041121595831000_B88","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jsbmb.2013.08.001","article-title":"Potency of progestogens used in hormonal therapy: toward understanding differential actions","volume":"142","author":"Hapgood","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2019041121595831000_B89","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pharmthera.2016.06.002","article-title":"Glucocorticoid-independent modulation of GR activity: implications for immunotherapy","volume":"165","author":"Hapgood","year":"2016","journal-title":"Pharmacol Ther"},{"issue":"3","key":"2019041121595831000_B90","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1210\/me.2014-1315","article-title":"Minireview: tipping the balance: ligand-independent activation of steroid receptors","volume":"29","author":"Bennesch","year":"2015","journal-title":"Mol Endocrinol"},{"issue":"12","key":"2019041121595831000_B91","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nrm.2016.122","article-title":"Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors","volume":"17","author":"Levin","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1\u20132","key":"2019041121595831000_B92","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000362724","article-title":"One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids","volume":"22","author":"Cruz-Topete","year":"2015","journal-title":"Neuroimmunomodulation"},{"issue":"7560","key":"2019041121595831000_B93","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature14583","article-title":"Progesterone receptor modulates ER\u03b1 action in breast cancer","volume":"523","author":"Mohammed","year":"2015","journal-title":"Nature"},{"issue":"1","key":"2019041121595831000_B94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.thromres.2011.12.009","article-title":"A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women","volume":"130","author":"Dahm","year":"2012","journal-title":"Thromb Res"},{"issue":"16","key":"2019041121595831000_B95","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1073\/pnas.1424814112","article-title":"Long-acting progestin-only contraceptives impair endometrial vasculature by inhibiting uterine vascular smooth muscle cell survival","volume":"112","author":"Kayisli","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2019041121595831000_B96","doi-asserted-by":"crossref","first-page":"e0137855","DOI":"10.1371\/journal.pone.0137855","article-title":"Progestins upregulate FKBP51 expression in human endometrial stromal cells to induce functional progesterone and glucocorticoid withdrawal: implications for contraceptive-associated abnormal uterine bleeding","volume":"10","author":"Guzeloglu Kayisli","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"2019041121595831000_B97","doi-asserted-by":"crossref","first-page":"R1036","DOI":"10.1186\/bcr1340","article-title":"The progestational and androgenic properties of medroxyprogesterone acetate: gene regulatory overlap with dihydrotestosterone in breast cancer cells","volume":"7","author":"Ghatge","year":"2005","journal-title":"Breast Cancer Res"},{"issue":"11","key":"2019041121595831000_B98","doi-asserted-by":"crossref","first-page":"e50167","DOI":"10.1371\/journal.pone.0050167","article-title":"Progesterone acts via the nuclear glucocorticoid receptor to suppress IL-1\u03b2-induced COX-2 expression in human term myometrial cells","volume":"7","author":"Lei","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"2019041121595831000_B99","doi-asserted-by":"crossref","first-page":"E719","DOI":"10.1210\/jc.2011-3251","article-title":"Progesterone receptor-A and -B have opposite effects on proinflammatory gene expression in human myometrial cells: implications for progesterone actions in human pregnancy and parturition","volume":"97","author":"Tan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019041121595831000_B100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.mce.2008.10.008","article-title":"Ligand-selective transactivation and transrepression via the glucocorticoid receptor: role of cofactor interaction","volume":"299","author":"Ronacher","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"2019041121595831000_B101","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbrc.2013.02.086","article-title":"Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy","volume":"433","author":"Africander","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"2019041121595831000_B102","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jsbmb.2014.05.007","article-title":"A comparative study of the androgenic properties of progesterone and the progestins, medroxyprogesterone acetate (MPA) and norethisterone acetate (NET-A)","volume":"143","author":"Africander","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1\u20132","key":"2019041121595831000_B103","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2005.07.001","article-title":"Synthetic progestins used in HRT have different glucocorticoid agonist properties","volume":"242","author":"Koubovec","year":"2005","journal-title":"Mol Cell Endocrinol"},{"issue":"1\u20132","key":"2019041121595831000_B104","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mce.2004.03.006","article-title":"Medroxyprogesterone acetate downregulates cytokine gene expression in mouse fibroblast cells","volume":"221","author":"Koubovec","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"2019041121595831000_B105","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1210\/jc.2007-0044","article-title":"Formation of ethinyl estradiol in women during treatment with norethindrone acetate","volume":"92","author":"Chu","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019041121595831000_B106","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/13697130701380434","article-title":"Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications","volume":"10","author":"Kuhl","year":"2007","journal-title":"Climacteric"},{"issue":"6","key":"2019041121595831000_B107","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1177\/1933719112438061","article-title":"The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis","volume":"19","author":"Chwalisz","year":"2012","journal-title":"Reprod Sci"},{"issue":"6","key":"2019041121595831000_B108","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0010-7824(97)00174-1","article-title":"In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women","volume":"56","author":"Kuhnz","year":"1997","journal-title":"Contraception"},{"issue":"45","key":"2019041121595831000_B109","doi-asserted-by":"crossref","first-page":"31136","DOI":"10.1074\/jbc.M114.587311","article-title":"Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent manner","volume":"289","author":"Louw-du Toit","year":"2014","journal-title":"J Biol Chem"},{"issue":"2","key":"2019041121595831000_B110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/mend.15.2.0596","article-title":"New antiprogestins with partial agonist activity: potential selective progesterone receptor modulators (SPRMs) and probes for receptor- and coregulator-induced changes in progesterone receptor induction properties","volume":"15","author":"Giannoukos","year":"2001","journal-title":"Mol Endocrinol"},{"issue":"2","key":"2019041121595831000_B111","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.steroids.2007.10.003","article-title":"Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile","volume":"73","author":"Sasagawa","year":"2008","journal-title":"Steroids"},{"issue":"9","key":"2019041121595831000_B112","doi-asserted-by":"crossref","first-page":"e24639","DOI":"10.1371\/journal.pone.0024639","article-title":"Medroxyprogesterone acetate alters Mycobacterium bovis BCG-induced cytokine production in peripheral blood mononuclear cells of contraceptive users","volume":"6","author":"Kleynhans","year":"2011","journal-title":"PLoS One"},{"key":"2019041121595831000_B113","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/B978-0-12-381270-4.00016-0","article-title":"Inferring mechanisms from dose-response curves","volume":"487","author":"Chow","year":"2011","journal-title":"Methods Enzymol"},{"issue":"11","key":"2019041121595831000_B114","first-page":"4055","article-title":"Dissociative glucocorticoid activity of medroxyprogesterone acetate in normal human lymphocytes","volume":"84","author":"Bamberger","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041121595831000_B115","doi-asserted-by":"crossref","first-page":"e96497","DOI":"10.1371\/journal.pone.0096497","article-title":"The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor","volume":"9","author":"Govender","year":"2014","journal-title":"PLoS One"},{"issue":"13\u201314","key":"2019041121595831000_B116","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.intimp.2003.08.005","article-title":"Receptor density dictates the behavior of a subset of steroid ligands in glucocorticoid receptor-mediated transrepression","volume":"3","author":"Zhao","year":"2003","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"2019041121595831000_B117","doi-asserted-by":"crossref","first-page":"e64831","DOI":"10.1371\/journal.pone.0064831","article-title":"Impact of glucocorticoid receptor density on ligand-independent dimerization, cooperative ligand-binding and basal priming of transactivation: a cell culture model","volume":"8","author":"Robertson","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"2019041121595831000_B118","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jsbmb.2005.06.032","article-title":"Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells","volume":"97","author":"Bray","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"2019041121595831000_B119","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.contraception.2014.01.026","article-title":"Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate","volume":"89","author":"Beasley","year":"2014","journal-title":"Contraception"},{"issue":"1","key":"2019041121595831000_B120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0010-7824(94)00003-F","article-title":"Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays","volume":"51","author":"Fuhrmann","year":"1995","journal-title":"Contraception"},{"issue":"9","key":"2019041121595831000_B121","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/0006-2952(83)90474-4","article-title":"Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes","volume":"32","author":"Kontula","year":"1983","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"2019041121595831000_B122","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1210\/en.2012-1850","article-title":"Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms","volume":"154","author":"Huijbregts","year":"2013","journal-title":"Endocrinology"},{"issue":"6","key":"2019041121595831000_B123","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/aji.12214","article-title":"Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis","volume":"71","author":"Hapgood","year":"2014","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"2019041121595831000_B124","doi-asserted-by":"crossref","first-page":"e0121135","DOI":"10.1371\/journal.pone.0121135","article-title":"Molecular mechanisms linking high dose medroxyprogesterone with HIV-1 risk","volume":"10","author":"Irvin","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"2019041121595831000_B125","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1210\/en.2013-1066","article-title":"Immunosuppressive biological mechanisms support reassessment of use of the injectable contraceptive medroxyprogesterone acetate","volume":"154","author":"Hapgood","year":"2013","journal-title":"Endocrinology"},{"issue":"2","key":"2019041121595831000_B126","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.contraception.2014.02.006","article-title":"Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs","volume":"90","author":"Huijbregts","year":"2014","journal-title":"Contraception"},{"issue":"5","key":"2019041121595831000_B127","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/humrep\/dev035","article-title":"Medroxyprogesterone acetate impairs human dendritic cell activation and function","volume":"30","author":"Quispe Calla","year":"2015","journal-title":"Hum Reprod"},{"issue":"5","key":"2019041121595831000_B128","doi-asserted-by":"crossref","first-page":"e62895","DOI":"10.1371\/journal.pone.0062895","article-title":"The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor","volume":"8","author":"Tomasicchio","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"2019041121595831000_B129","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/QAD.0000000000000681","article-title":"Medroxyprogesterone acetate increases HIV-1 infection of unstimulated peripheral blood mononuclear cells in vitro","volume":"29","author":"Sampah","year":"2015","journal-title":"AIDS"},{"issue":"11","key":"2019041121595831000_B130","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/infdis\/jiu832","article-title":"Medroxyprogesterone acetate regulates HIV-1 uptake and transcytosis but not replication in primary genital epithelial cells, resulting in enhanced T-cell infection","volume":"211","author":"Ferreira","year":"2015","journal-title":"J Infect Dis"},{"issue":"4","key":"2019041121595831000_B131","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1128\/IAI.01189-12","article-title":"The contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosis","volume":"81","author":"Kleynhans","year":"2013","journal-title":"Infect Immun"},{"issue":"7","key":"2019041121595831000_B132","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.4049\/jimmunol.1103054","article-title":"Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infection","volume":"189","author":"Vicetti Miguel","year":"2012","journal-title":"J Immunol"},{"issue":"6","key":"2019041121595831000_B133","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/mi.2016.22","article-title":"Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection","volume":"9","author":"Quispe Calla","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"10","key":"2019041121595831000_B134","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/QAD.0000000000000294","article-title":"Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques","volume":"28","author":"Radzio","year":"2014","journal-title":"AIDS"},{"issue":"4","key":"2019041121595831000_B135","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/QAI.0000000000000975","article-title":"A depot medroxyprogesterone acetate dose that models human use and its effect on vaginal SHIV acquisition risk","volume":"72","author":"Butler","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2\u20133","key":"2019041121595831000_B136","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jsbmb.2010.03.058","article-title":"The role of the glucocorticoid receptor in inflammation and immunity","volume":"120","author":"Baschant","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"2019041121595831000_B137","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1186\/1471-2164-15-656","article-title":"Glucocorticoid receptor coordinates transcription factor-dominated regulatory network in macrophages","volume":"15","author":"Chinenov","year":"2014","journal-title":"BMC Genomics"},{"issue":"1\u20132","key":"2019041121595831000_B138","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mce.2013.04.006","article-title":"Nuclear receptors in inflammation control: repression by GR and beyond","volume":"380","author":"Chinenov","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"2019041121595831000_B139","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tem.2012.11.005","article-title":"The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore","volume":"24","author":"Busillo","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"2019041121595831000_B140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-4939-2895-8_8","article-title":"Glucocorticoid-induced osteoporosis","volume":"872","author":"Frenkel","year":"2015","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"2019041121595831000_B141","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S1471-4906(03)00173-X","article-title":"How stress influences the immune response","volume":"24","author":"Padgett","year":"2003","journal-title":"Trends Immunol"},{"issue":"5","key":"2019041121595831000_B142","doi-asserted-by":"crossref","first-page":"e63587","DOI":"10.1371\/journal.pone.0063587","article-title":"Viral infection increases glucocorticoid-induced interleukin-10 production through ERK-mediated phosphorylation of the glucocorticoid receptor in dendritic cells: potential clinical implications","volume":"8","author":"Ng","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"2019041121595831000_B143","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00705-010-0678-0","article-title":"Modulation of HIV-1 virulence via the host glucocorticoid receptor: towards further understanding the molecular mechanisms of HIV-1 pathogenesis","volume":"155","author":"Hapgood","year":"2010","journal-title":"Arch Virol"},{"issue":"1","key":"2019041121595831000_B144","doi-asserted-by":"crossref","first-page":"37723","DOI":"10.1038\/srep37723","article-title":"Dendritic cell function and pathogen-specific T cell immunity are inhibited in mice administered levonorgestrel prior to intranasal Chlamydia trachomatis infection","volume":"6","author":"Quispe Calla","year":"2016","journal-title":"Sci Rep"},{"key":"2019041121595831000_B145","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/B978-012491543-5\/50101-7","volume-title":"Mucosal Immunol.","author":"Wira","year":"2005","edition":"3rd ed."},{"issue":"11","key":"2019041121595831000_B146","doi-asserted-by":"crossref","first-page":"e1001190","DOI":"10.1371\/journal.ppat.1001190","article-title":"Should the human microbiome be considered when developing vaccines","volume":"6","author":"Ferreira","year":"2010","journal-title":"PLoS Pathog"},{"issue":"9","key":"2019041121595831000_B147","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/infdis\/jiv233","article-title":"CCR5 expression levels in HIV-uninfected women receiving hormonal contraception","volume":"212","author":"Sciaranghella","year":"2015","journal-title":"J Infect Dis"},{"issue":"3","key":"2019041121595831000_B148","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1089\/aid.2012.0271","article-title":"Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues","volume":"29","author":"Chandra","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1\u20132","key":"2019041121595831000_B149","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0165-0378(01)00125-5","article-title":"Oral contraceptive use induces upregulation of the CCR5 chemokine receptor on CD4+ T cells in the cervical epithelium of healthy women","volume":"54","author":"Prakash","year":"2002","journal-title":"J Reprod Immunol"},{"issue":"4","key":"2019041121595831000_B150","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(15)00429-6","article-title":"Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study","volume":"16","author":"Byrne","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2019041121595831000_B151","doi-asserted-by":"crossref","first-page":"489.e1-9","DOI":"10.1016\/j.ajog.2014.05.016","article-title":"Changes in genital tract immune cell populations after initiation of intrauterine contraception","volume":"211","author":"Achilles","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2019041121595831000_B152","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/mi.2016.121","article-title":"Effects of depot-medroxyprogesterone acetate on the immune microenvironment of the human cervix and endometrium: implications for HIV susceptibility","volume":"10","author":"Smith-McCune","year":"2017","journal-title":"Mucosal Immunol"},{"issue":"5","key":"2019041121595831000_B153","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/QAI.0000000000000531","article-title":"Effect of hormonal contraception on the function of plasmacytoid dendritic cells and distribution of immune cell populations in the female reproductive tract","volume":"68","author":"Michel","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"2019041121595831000_B154","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.4049\/jimmunol.180.4.2029","article-title":"Cutting edge: progesterone regulates IFN-\u03b1 production by plasmacytoid dendritic cells","volume":"180","author":"Hughes","year":"2008","journal-title":"J Immunol"},{"issue":"3","key":"2019041121595831000_B155","first-page":"431","article-title":"Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium","volume":"96","author":"Miller","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2019041121595831000_B156","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.contraception.2014.01.024","article-title":"Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate","volume":"90","author":"Bahamondes","year":"2014","journal-title":"Contraception"},{"issue":"1","key":"2019041121595831000_B157","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0010-7824(99)00058-X","article-title":"The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy","volume":"60","author":"Mauck","year":"1999","journal-title":"Contraception"},{"issue":"1","key":"2019041121595831000_B158","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0010-7824(00)00132-3","article-title":"The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera","volume":"62","author":"Bahamondes","year":"2000","journal-title":"Contraception"},{"issue":"2","key":"2019041121595831000_B159","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/QAI.0000000000000103","article-title":"Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion","volume":"66","author":"Morrison","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"2019041121595831000_B160","doi-asserted-by":"crossref","first-page":"e00221-15","DOI":"10.1128\/mBio.00221-15","article-title":"The contribution of cervicovaginal infections to the immunomodulatory effects of hormonal contraception","volume":"6","author":"Fichorova","year":"2015","journal-title":"MBio"},{"issue":"3","key":"2019041121595831000_B161","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.fertnstert.2007.01.046","article-title":"Effect of mifepristone on the expression of endometrial secretory leukocyte protease inhibitor in new medroxyprogesterone acetate users","volume":"90","author":"Li","year":"2008","journal-title":"Fertil Steril"},{"issue":"4","key":"2019041121595831000_B162","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/aji.12415","article-title":"Injectable progestin-only contraception is associated with increased levels of pro-inflammatory cytokines in the female genital tract","volume":"74","author":"Deese","year":"2015","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"2019041121595831000_B163","doi-asserted-by":"crossref","first-page":"e0143109","DOI":"10.1371\/journal.pone.0143109","article-title":"Immune activation in the female genital tract: expression profiles of soluble proteins in women at high risk for HIV infection","volume":"11","author":"Francis","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"2019041121595831000_B164","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/QAI.0000000000000866","article-title":"Changes in vaginal microbiota and immune mediators in HIV-1-seronegative Kenyan women initiating depot medroxyprogesterone acetate","volume":"71","author":"Roxby","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"2019041121595831000_B165","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0015-0282(02)04930-0","article-title":"Hormonal contraception can suppress natural antimicrobial gene transcription in human endometrium","volume":"79","author":"Fleming","year":"2003","journal-title":"Fertil Steril"},{"issue":"7","key":"2019041121595831000_B166","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/1933719114565035","article-title":"Progestin-containing contraceptives alter expression of host defense-related genes of the endometrium and cervix","volume":"22","author":"Goldfien","year":"2015","journal-title":"Reprod Sci"},{"key":"2019041121595831000_B167","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jri.2015.03.007","article-title":"Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive","volume":"110","author":"Ngcapu","year":"2015","journal-title":"J Reprod Immunol"},{"issue":"9","key":"2019041121595831000_B168","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/424600","article-title":"Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of Depo-Provera before intravaginal challenge with simian immunodeficiency virus mac239","volume":"190","author":"Abel","year":"2004","journal-title":"J Infect Dis"},{"issue":"4\u20135","key":"2019041121595831000_B169","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1600-0684.2007.00244.x","article-title":"Depo-Provera abrogates attenuated lentivirus-induced protection in male rhesus macaques challenged intravenously with pathogenic SIVmac239","volume":"36","author":"Genesc\u00e0","year":"2007","journal-title":"J Med Primatol"},{"key":"2019041121595831000_B170","first-page":"S125","article-title":"Effects of two progestin-only contraceptives, Depo-Provera and Norplant-II, on the vaginal epithelium of rhesus monkeys","volume":"14","author":"Hild-Petito","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"2019041121595831000_B171","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jmp.12188","article-title":"Analysis of putative mucosal SHIV susceptibility factors during repeated DMPA treatments in pigtail macaques","volume":"44","author":"Butler","year":"2015","journal-title":"J Med Primatol"},{"issue":"8","key":"2019041121595831000_B172","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1128\/JVI.77.8.4558-4565.2003","article-title":"Progesterone increases susceptibility and decreases immune responses to genital herpes infection","volume":"77","author":"Kaushic","year":"2003","journal-title":"J Virol"},{"issue":"2","key":"2019041121595831000_B173","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/jmp.12157","article-title":"A combined oral contraceptive affects mucosal SHIV susceptibility factors in a pigtail macaque (Macaca nemestrina) model","volume":"44","author":"Dietz Ostergaard","year":"2015","journal-title":"J Med Primatol"},{"issue":"5","key":"2019041121595831000_B174","doi-asserted-by":"crossref","first-page":"e97767","DOI":"10.1371\/journal.pone.0097767","article-title":"Sex hormones selectively impact the endocervical mucosal microenvironment: implications for HIV transmission","volume":"9","author":"Goode","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"2019041121595831000_B175","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/modpathol.3880050","article-title":"Hormonal pathology of the endometrium","volume":"13","author":"Deligdisch","year":"2000","journal-title":"Mod Pathol"},{"issue":"5","key":"2019041121595831000_B176","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.contraception.2015.01.008","article-title":"A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women","volume":"91","author":"Dinh","year":"2015","journal-title":"Contraception"},{"issue":"4","key":"2019041121595831000_B177","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00404-005-0079-x","article-title":"Lifetime changes in the vulva and vagina","volume":"273","author":"Farage","year":"2006","journal-title":"Arch Gynecol Obstet"},{"key":"2019041121595831000_B178","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-1-4757-3889-6_5","volume-title":"Blaustein\u2019s Pathology of the Female Genital Tract","author":"Ferenczy","year":"1994"},{"issue":"5","key":"2019041121595831000_B179","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00007435-200005000-00003","article-title":"Histologic development of cervical ectopy: relationship to reproductive hormones","volume":"27","author":"Jacobson","year":"2000","journal-title":"Sex Transm Dis"},{"key":"2019041121595831000_B180","first-page":"110","volume-title":"The Uterus","author":"Noyes","year":"1973"},{"issue":"1","key":"2019041121595831000_B181","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.ph.37.030175.001421","article-title":"Hormonal regulation of the reproductive tract in female mammals","volume":"37","author":"Brenner","year":"1975","journal-title":"Annu Rev Physiol"},{"issue":"8","key":"2019041121595831000_B182","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0002-9378(79)90302-8","article-title":"Proliferation kinetics of human endometrium during the normal menstrual cycle","volume":"133","author":"Ferenczy","year":"1979","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2019041121595831000_B183","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0010-7824(98)00047-X","article-title":"The effects of progesterone and progestins on endometrial proliferation","volume":"57","author":"Moyer","year":"1998","journal-title":"Contraception"},{"key":"2019041121595831000_B184","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/humrep\/15.suppl_1.119","article-title":"Morphological changes and protein secretion induced by progesterone in the endometrium during the luteal phase in preparation for nidation","volume":"15","author":"Bergeron","year":"2000","journal-title":"Hum Reprod"},{"issue":"12","key":"2019041121595831000_B185","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1002\/1097-0142(19901215)66:12<2620::AID-CNCR2820661226>3.0.CO;2-S","article-title":"Estrogen receptor localization in normal and neoplastic epithelium of the uterine cervix","volume":"66","author":"Nonogaki","year":"1990","journal-title":"Cancer"},{"issue":"6","key":"2019041121595831000_B186","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/1097-0142(19910915)68:6<1340::AID-CNCR2820680626>3.0.CO;2-Q","article-title":"Immunohistochemical analysis of estrogen receptors, progesterone receptors, Ki-67 antigen, and human papillomavirus DNA in normal and neoplastic epithelium of the uterine cervix","volume":"68","author":"Konishi","year":"1991","journal-title":"Cancer"},{"issue":"9","key":"2019041121595831000_B187","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0022-4731(76)90063-7","article-title":"Hormonal action in human cervix\u2014II. Specific progestogen binding proteins in human cervix","volume":"7","author":"Sanborn","year":"1976","journal-title":"J Steroid Biochem"},{"issue":"2","key":"2019041121595831000_B188","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1471-0528.1975.tb02204.x","article-title":"The uterine cervix from adolescence to the menopause","volume":"82","author":"Singer","year":"1975","journal-title":"Br J Obstet Gynaecol"},{"issue":"1","key":"2019041121595831000_B189","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0020-7292(99)00037-5","article-title":"Cervical ectopy and the transformation zone measured by computerized planimetry in adolescents","volume":"66","author":"Jacobson","year":"1999","journal-title":"Int J Gynaecol Obstet"},{"key":"2019041121595831000_B190","first-page":"S11","article-title":"Prevalence and correlates of HIV type 1 shedding in the female genital tract","volume":"14","author":"Mostad","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"2019041121595831000_B191","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1128\/CVI.00762-14","article-title":"Cross-sectional analysis of selected genital tract immunological markers and molecular vaginal microbiota in sub-Saharan African women, with relevance to HIV risk and prevention","volume":"22","author":"Kyongo","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"11","key":"2019041121595831000_B192","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/01.olq.0000216026.67352.f9","article-title":"Nested case-control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa","volume":"33","author":"Myer","year":"2006","journal-title":"Sex Transm Dis"},{"issue":"3","key":"2019041121595831000_B193","doi-asserted-by":"crossref","first-page":"e17480","DOI":"10.1371\/journal.pone.0017480","article-title":"Correlates of HIV-1 genital shedding in Tanzanian women","volume":"6","author":"Tanton","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"2019041121595831000_B194","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1210\/endo.139.10.6241","article-title":"Role of stromal and epithelial estrogen receptors in vaginal epithelial proliferation, stratification, and cornification","volume":"139","author":"Buchanan","year":"1998","journal-title":"Endocrinology"},{"issue":"4","key":"2019041121595831000_B195","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1067\/mob.2000.108857","article-title":"Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle","volume":"183","author":"Patton","year":"2000","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2019041121595831000_B196","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1067\/mob.2001.119627","article-title":"Expression of estrogen receptor isoforms alpha and beta messenger RNA in vaginal tissue of premenopausal and postmenopausal women","volume":"185","author":"Gebhart","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2019041121595831000_B197","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/aji.12230","article-title":"The structure of the human vaginal stratum corneum and its role in immune defense","volume":"71","author":"Anderson","year":"2014","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"2019041121595831000_B198","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0378-5122(94)00863-3","article-title":"The vaginal epithelium in the postmenopause\u2014cytology, histology and pH as methods of assessment","volume":"21","author":"Nilsson","year":"1995","journal-title":"Maturitas"},{"issue":"2","key":"2019041121595831000_B199","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jri.2011.01.005","article-title":"Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections","volume":"88","author":"Hickey","year":"2011","journal-title":"J Reprod Immunol"},{"issue":"15","key":"2019041121595831000_B200","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1097\/QAD.0b013e3283060ea4","article-title":"A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle","volume":"22","author":"Wira","year":"2008","journal-title":"AIDS"},{"issue":"1","key":"2019041121595831000_B201","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.0105-2896.2005.00287.x","article-title":"Innate and adaptive immunity in female genital tract: cellular responses and interactions","volume":"206","author":"Wira","year":"2005","journal-title":"Immunol Rev"},{"issue":"2","key":"2019041121595831000_B202","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jri.2010.12.004","article-title":"Increased prevalence of sexually transmitted viral infections in women: the role of female sex hormones in regulating susceptibility and immune responses","volume":"88","author":"Kaushic","year":"2011","journal-title":"J Reprod Immunol"},{"issue":"5728","key":"2019041121595831000_B203","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.1112489","article-title":"HIV\/AIDS in women: an expanding epidemic","volume":"308","author":"Quinn","year":"2005","journal-title":"Science"},{"issue":"9492","key":"2019041121595831000_B204","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(05)67481-8","article-title":"Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study","volume":"366","author":"Gray","year":"2005","journal-title":"Lancet"},{"issue":"15","key":"2019041121595831000_B205","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/QAD.0b013e32834a9338","article-title":"Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1-serodiscordant couples","volume":"25","author":"Mugo","year":"2011","journal-title":"AIDS"},{"issue":"6664","key":"2019041121595831000_B206","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/34571","article-title":"A new classification for HIV-1","volume":"391","author":"Berger","year":"1998","journal-title":"Nature"},{"issue":"1","key":"2019041121595831000_B207","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00001432-200502000-00003","article-title":"Assessing chemokine co-receptor usage in HIV","volume":"18","author":"Coakley","year":"2005","journal-title":"Curr Opin Infect Dis"},{"issue":"21","key":"2019041121595831000_B208","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019041121595831000_B209","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/cid\/ciw663","article-title":"Cervicovaginal inflammation facilitates acquisition of less infectious HIV variants","volume":"64","author":"Selhorst","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2019041121595831000_B210","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.chom.2016.02.002","article-title":"HIV-host interactions: implications for vaccine design","volume":"19","author":"Haynes","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"1","key":"2019041121595831000_B211","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.med.60.041807.123549","article-title":"Emerging concepts in the immunopathogenesis of AIDS","volume":"60","author":"Douek","year":"2009","journal-title":"Annu Rev Med"},{"issue":"19","key":"2019041121595831000_B212","doi-asserted-by":"crossref","first-page":"10189","DOI":"10.1128\/JVI.02529-10","article-title":"HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo","volume":"85","author":"Meditz","year":"2011","journal-title":"J Virol"},{"issue":"10","key":"2019041121595831000_B213","doi-asserted-by":"crossref","first-page":"e1004467","DOI":"10.1371\/journal.ppat.1004467","article-title":"CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cells","volume":"10","author":"Micci","year":"2014","journal-title":"PLoS Pathog"},{"issue":"6","key":"2019041121595831000_B214","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri2302","article-title":"Setting the stage: host invasion by HIV","volume":"8","author":"Hladik","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"2019041121595831000_B215","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/imr.12072","article-title":"Mucosal immunology of HIV infection","volume":"254","author":"Xu","year":"2013","journal-title":"Immunol Rev"},{"issue":"2","key":"2019041121595831000_B216","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.immuni.2007.01.007","article-title":"Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1","volume":"26","author":"Hladik","year":"2007","journal-title":"Immunity"},{"key":"2019041121595831000_B217","doi-asserted-by":"crossref","first-page":"S667","DOI":"10.1093\/infdis\/jiu369","article-title":"Origin of the transmitted virus in HIV infection: infected cells versus cell-free virus","volume":"210","author":"Sagar","year":"2014","journal-title":"J Infect Dis"},{"issue":"6","key":"2019041121595831000_B218","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.it.2006.04.007","article-title":"HIV infection: first battle decides the war","volume":"27","author":"Hel","year":"2006","journal-title":"Trends Immunol"},{"key":"2019041121595831000_B219","doi-asserted-by":"crossref","first-page":"S606","DOI":"10.1093\/infdis\/jiu538","article-title":"Cell-associated HIV mucosal transmission: the neglected pathway","volume":"210","author":"Anderson","year":"2014","journal-title":"J Infect Dis"},{"issue":"11","key":"2019041121595831000_B220","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/014107689208501119","article-title":"HIV infection in a patient with Meyer-Rokitansky-K\u00fcster-Hauser syndrome","volume":"85","author":"Kell","year":"1992","journal-title":"J R Soc Med"},{"issue":"2\u20133","key":"2019041121595831000_B221","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0684.1992.tb00569.x","article-title":"Mechanism of genital transmission of SIV: a hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques","volume":"21","author":"Miller","year":"1992","journal-title":"J Med Primatol"},{"issue":"6","key":"2019041121595831000_B222","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/aji.12221","article-title":"Influence of common mucosal co-factors on HIV infection in the female genital tract","volume":"71","author":"Ferreira","year":"2014","journal-title":"Am J Reprod Immunol"},{"issue":"10","key":"2019041121595831000_B223","doi-asserted-by":"crossref","first-page":"e1004440","DOI":"10.1371\/journal.ppat.1004440","article-title":"Vaginal challenge with an SIV-based dual reporter system reveals that infection can occur throughout the upper and lower female reproductive tract","volume":"10","author":"Stieh","year":"2014","journal-title":"PLoS Pathog"},{"issue":"3","key":"2019041121595831000_B224","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0002-9378(72)90687-4","article-title":"Estrogenic activity in women receiving an injectable progestogen for contraception","volume":"113","author":"Mishell","year":"1972","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2019041121595831000_B225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0000000000000805","article-title":"Critical review: mechanisms of HIV transmission in Depo-Provera users: the likely role of hypoestrogenism","volume":"71","author":"Hickey","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"2019041121595831000_B226","doi-asserted-by":"crossref","first-page":"e1005589","DOI":"10.1371\/journal.ppat.1005589","article-title":"Estradiol enhances CD4+ T-cell anti-viral immunity by priming vaginal DCs to induce Th17 responses via an IL-1-dependent pathway","volume":"12","author":"Anipindi","year":"2016","journal-title":"PLoS Pathog"},{"issue":"2","key":"2019041121595831000_B227","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/aji.12252","article-title":"Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens","volume":"72","author":"Wira","year":"2014","journal-title":"Am J Reprod Immunol"},{"issue":"10","key":"2019041121595831000_B228","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nm1096-1084","article-title":"Progesterone implants enhance SIV vaginal transmission and early virus load","volume":"2","author":"Marx","year":"1996","journal-title":"Nat Med"},{"issue":"3","key":"2019041121595831000_B229","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1086\/315776","article-title":"Estrogen protects against vaginal transmission of simian immunodeficiency virus","volume":"182","author":"Smith","year":"2000","journal-title":"J Infect Dis"},{"issue":"11","key":"2019041121595831000_B230","doi-asserted-by":"crossref","first-page":"e26602","DOI":"10.1371\/journal.pone.0026602","article-title":"Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness","volume":"6","author":"Hummelen","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"2019041121595831000_B231","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.maturitas.2007.09.009","article-title":"A study of 17\u03b2-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy","volume":"58","author":"Cotreau","year":"2007","journal-title":"Maturitas"},{"issue":"12","key":"2019041121595831000_B232","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1097\/01.aids.0000131393.76221.cc","article-title":"Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect","volume":"18","author":"Smith","year":"2004","journal-title":"AIDS"},{"issue":"5","key":"2019041121595831000_B233","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1128\/JVI.79.5.3107-3116.2005","article-title":"Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation","volume":"79","author":"Gillgrass","year":"2005","journal-title":"J Virol"},{"issue":"48","key":"2019041121595831000_B234","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1016\/j.vaccine.2008.08.045","article-title":"Intranasal and subcutaneous immunization under the effect of estradiol leads to better protection against genital HSV-2 challenge compared to progesterone","volume":"26","author":"Bhavanam","year":"2008","journal-title":"Vaccine"},{"issue":"1\u20132","key":"2019041121595831000_B235","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jri.2009.07.005","article-title":"Mucosal immunology of the genital and gastrointestinal tracts and HIV-1 infection","volume":"83","author":"Mestecky","year":"2009","journal-title":"J Reprod Immunol"},{"issue":"2","key":"2019041121595831000_B236","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0378-5122(90)90089-O","article-title":"Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause","volume":"12","author":"Molander","year":"1990","journal-title":"Maturitas"},{"key":"2019041121595831000_B237","first-page":"1","article-title":"Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring","volume":"157","author":"Smith","year":"1993","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"2019041121595831000_B238","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.maturitas.2005.06.014","article-title":"Management of post-menopausal vaginal atrophy and atrophic vaginitis","volume":"52","author":"Castelo-Branco","year":"2005","journal-title":"Maturitas"},{"issue":"6","key":"2019041121595831000_B239","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0015-0282(01)01796-4","article-title":"Progesterone increases the number of Langerhans cells in human vaginal epithelium","volume":"75","author":"Wieser","year":"2001","journal-title":"Fertil Steril"},{"issue":"1","key":"2019041121595831000_B240","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1084\/jem.174.1.289","article-title":"Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission","volume":"174","author":"Klebanoff","year":"1991","journal-title":"J Exp Med"},{"issue":"6","key":"2019041121595831000_B241","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1086\/315127","article-title":"Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition","volume":"180","author":"Martin","year":"1999","journal-title":"J Infect Dis"},{"issue":"13","key":"2019041121595831000_B242","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/00002030-199813000-00019","article-title":"Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV","volume":"12","author":"Taha","year":"1998","journal-title":"AIDS"},{"issue":"12","key":"2019041121595831000_B243","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/QAD.0b013e3283021a37","article-title":"Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies","volume":"22","author":"Atashili","year":"2008","journal-title":"AIDS"},{"issue":"4","key":"2019041121595831000_B244","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/aid.2009.0185","article-title":"Depo-Provera does not alter disease progression in SIVmac-infected female Chinese rhesus macaques","volume":"26","author":"Sanders-Beer","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2019041121595831000_B245","first-page":"S119","article-title":"Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks","volume":"14","author":"Sodora","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"2019041121595831000_B246","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/QAI.0b013e318220ebd3","article-title":"High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques","volume":"57","author":"Vishwanathan","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"2019041121595831000_B247","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1677\/joe.1.06873","article-title":"Cyclic changes in the vaginal epithelium of normal rhesus macaques","volume":"190","author":"Poonia","year":"2006","journal-title":"J Endocrinol"},{"issue":"3","key":"2019041121595831000_B248","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0010-7824(76)90101-3","article-title":"Plasma levels of medroxyprogesterone acetate (MPA), estradiol and progesterone in the rhesus monkey after intramuscular adminstration of Depo-Provera","volume":"14","author":"Mora","year":"1976","journal-title":"Contraception"},{"issue":"12","key":"2019041121595831000_B249","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/OLQ.0000000000000367","article-title":"Relationship of estimated SHIV acquisition time points during the menstrual cycle and thinning of vaginal epithelial layers in pigtail macaques","volume":"42","author":"Kersh","year":"2015","journal-title":"Sex Transm Dis"},{"issue":"3","key":"2019041121595831000_B250","first-page":"369","article-title":"A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2","volume":"70","author":"Parr","year":"1994","journal-title":"Lab Invest"},{"key":"2019041121595831000_B251","unstructured":"World Health Organization . Global incidence and prevalence of selected curable sexually transmitted infections\u20142008. Available at: http:\/\/apps.who.int\/iris\/handle\/10665\/75181. Accessed 31 December 2017."},{"key":"2019041121595831000_B252","unstructured":"World Health Organization . Sexually transmitted infections (STIs). Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs110\/en\/. Accessed 31 December 2017."},{"issue":"10","key":"2019041121595831000_B253","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2471\/BLT.07.046128","article-title":"An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection","volume":"86","author":"Looker","year":"2008","journal-title":"Bull World Health Organ"},{"issue":"6","key":"2019041121595831000_B254","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/01.olq.0000154504.54686.d1","article-title":"Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection","volume":"32","author":"Sexton","year":"2005","journal-title":"Sex Transm Dis"},{"issue":"4","key":"2019041121595831000_B255","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/COH.0b013e32833a8844","article-title":"Contribution of sexually transmitted infections to the sexual transmission of HIV","volume":"5","author":"Ward","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"issue":"9878","key":"2019041121595831000_B256","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(12)62204-1","article-title":"National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis","volume":"381","author":"Alkema","year":"2013","journal-title":"Lancet"},{"issue":"9879","key":"2019041121595831000_B257","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(13)60597-8","article-title":"Trends in contraceptive need and use in developing countries in 2003, 2008, and 2012: an analysis of national surveys","volume":"381","author":"Darroch","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"2019041121595831000_B258","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bpobgyn.2008.11.004","article-title":"Highly effective contraception and acquisition of HIV and other sexually transmitted infections","volume":"23","author":"Morrison","year":"2009","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"2","key":"2019041121595831000_B259","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.contraception.2005.08.012","article-title":"Hormonal contraceptive use and risk of sexually transmitted infections: a systematic review","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"key":"2019041121595831000_B260","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/aji.12029","article-title":"Assessing the relationship between cervical ectopy and HIV susceptibility: implications for HIV prevention in women","volume":"69","author":"Venkatesh","year":"2013","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"2019041121595831000_B261","doi-asserted-by":"crossref","first-page":"e0147029","DOI":"10.1371\/journal.pone.0147029","article-title":"The influence of hormonal factors on the risk of developing cervical cancer and pre-cancer: results from the EPIC cohort","volume":"11","author":"Roura","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"2019041121595831000_B262","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1016\/S2214-109X(15)00086-8","article-title":"Use of injectable hormonal contraception and women\u2019s risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda","volume":"3","author":"Grabowski","year":"2015","journal-title":"Lancet Glob Health"},{"issue":"3","key":"2019041121595831000_B263","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0897.2010.00965.x","article-title":"HIV-1 infection in the female reproductive tract: role of interactions between HIV-1 and genital epithelial cells","volume":"65","author":"Kaushic","year":"2011","journal-title":"Am J Reprod Immunol"},{"issue":"5","key":"2019041121595831000_B264","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/jmp.12177","article-title":"Relationship of menstrual cycle and vaginal infection in female rhesus macaques challenged with repeated, low doses of SIVmac251","volume":"44","author":"Morris","year":"2015","journal-title":"J Med Primatol"},{"issue":"6","key":"2019041121595831000_B265","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/aji.12246","article-title":"Non-human primate models of hormonal contraception and HIV","volume":"71","author":"McNicholl","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"2019041121595831000_B266","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fmicb.2011.00107","article-title":"Estradiol-treated female mice as surrogate hosts for Neisseria gonorrhoeae genital tract infections","volume":"2","author":"Jerse","year":"2011","journal-title":"Front Microbiol"},{"issue":"13","key":"2019041121595831000_B267","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1097\/QAD.0b013e32836290b6","article-title":"Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission","volume":"27","author":"van de Wijgert","year":"2013","journal-title":"AIDS"},{"issue":"8","key":"2019041121595831000_B268","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"5421","key":"2019041121595831000_B269","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"issue":"7241","key":"2019041121595831000_B270","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/nature07831","article-title":"Glycerol monolaurate prevents mucosal SIV transmission","volume":"458","author":"Li","year":"2009","journal-title":"Nature"},{"issue":"24","key":"2019041121595831000_B271","doi-asserted-by":"crossref","first-page":"13443","DOI":"10.1128\/JVI.05615-11","article-title":"Vaginal Langerhans cells nonproductively transporting HIV-1 mediate infection of T cells","volume":"85","author":"Ballweber","year":"2011","journal-title":"J Virol"},{"issue":"1","key":"2019041121595831000_B272","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12977-014-0123-7","article-title":"Caveolin-1 mediated uptake via langerin restricts HIV-1 infection in human Langerhans cells","volume":"11","author":"van den Berg","year":"2014","journal-title":"Retrovirology"},{"issue":"3","key":"2019041121595831000_B273","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.tim.2017.01.009","article-title":"Langerhans cells: the \u201cyin and yang\u201d of HIV restriction and transmission","volume":"25","author":"Mayr","year":"2017","journal-title":"Trends Microbiol"},{"issue":"3","key":"2019041121595831000_B274","first-page":"571","article-title":"Influence of hormonal contraceptives on the immune cells and thickness of human vaginal epithelium","volume":"102","author":"Ildgruben","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2019041121595831000_B275","doi-asserted-by":"crossref","first-page":"969","DOI":"10.4049\/jimmunol.181.2.969","article-title":"Medroxyprogesterone acetate inhibits CD8+ T cell viral-specific effector function and induces herpes simplex virus type 1 reactivation","volume":"181","author":"Cherpes","year":"2008","journal-title":"J Immunol"},{"key":"2019041121595831000_B276","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","article-title":"Classification and pharmacology of progestins","volume":"46","author":"Schindler","year":"2003","journal-title":"Maturitas"},{"issue":"1","key":"2019041121595831000_B277","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00018-005-5390-y","article-title":"Glucocorticoids in T cell apoptosis and function","volume":"63","author":"Herold","year":"2006","journal-title":"Cell Mol Life Sci"},{"issue":"5\u20137","key":"2019041121595831000_B278","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.steroids.2005.02.006","article-title":"The human glucocorticoid receptor: one gene, multiple proteins and diverse responses","volume":"70","author":"Zhou","year":"2005","journal-title":"Steroids"},{"issue":"2-5","key":"2019041121595831000_B279","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0960-0760(03)00218-8","article-title":"Tissue glucocorticoid resistance\/hypersensitivity syndromes","volume":"85","author":"Kino","year":"2003","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"11","key":"2019041121595831000_B280","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.4049\/jimmunol.169.11.6361","article-title":"HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection","volume":"169","author":"Mirani","year":"2002","journal-title":"J Immunol"},{"issue":"1","key":"2019041121595831000_B281","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/JVI.66.1.586-590.1992","article-title":"Glucocorticoid receptor-binding site in the human immunodeficiency virus long terminal repeat","volume":"66","author":"Ghosh","year":"1992","journal-title":"J Virol"},{"issue":"12","key":"2019041121595831000_B282","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1089\/aid.1992.8.1977","article-title":"Regulatory elements in the human immunodeficiency virus type 1 long terminal repeat LTR (HIV-1) responsive to steroid hormone stimulation","volume":"8","author":"Kolesnitchenko","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"2019041121595831000_B283","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1006\/viro.1995.0062","article-title":"Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression","volume":"214","author":"Mitra","year":"1995","journal-title":"Virology"},{"issue":"4\u20135","key":"2019041121595831000_B284","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0960-0760(00)00187-4","article-title":"Glucocorticoids suppress human immunodeficiency virus type-1 long terminal repeat activity in a cell type-specific, glucocorticoid receptor-mediated fashion: direct protective effects at variance with clinical phenomenology","volume":"75","author":"Kino","year":"2000","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"9","key":"2019041121595831000_B285","first-page":"4588s","article-title":"Advances in the isolation of HTLV-III from patients with AIDS and AIDS-related complex and from donors at risk","volume":"45","author":"Markham","year":"1985","journal-title":"Cancer Res"},{"issue":"1","key":"2019041121595831000_B286","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ijc.2910370112","article-title":"Hydrocortisone and some other hormones enhance the expression of HTLV-III","volume":"37","author":"Markham","year":"1986","journal-title":"Int J Cancer"},{"issue":"2","key":"2019041121595831000_B287","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1006\/viro.1993.1317","article-title":"Identification of a novel glucocorticoid response element within the genome of the human immunodeficiency virus type 1","volume":"194","author":"Soudeyns","year":"1993","journal-title":"Virology"},{"issue":"12","key":"2019041121595831000_B288","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/nm1297-1302b","article-title":"Effects of RU486 on HIV-1 replication","volume":"3","author":"Soudeyns","year":"1997","journal-title":"Nat Med"},{"issue":"1","key":"2019041121595831000_B289","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.virol.2008.01.037","article-title":"Activation of the glucocorticoid receptor releases unstimulated PBMCs from an early block in HIV-1 replication","volume":"375","author":"Wiegers","year":"2008","journal-title":"Virology"},{"issue":"1","key":"2019041121595831000_B290","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1933719108325510","article-title":"The effect of progesterone levels and pregnancy on HIV-1 coreceptor expression","volume":"16","author":"Sheffield","year":"2009","journal-title":"Reprod Sci"},{"issue":"1\u20132","key":"2019041121595831000_B291","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jsbmb.2012.02.001","article-title":"Effects of progesterone on the content of CCR5 and CXCR4 coreceptors in PBMCs of seropositive and exposed but uninfected Mexican women to HIV-1","volume":"132","author":"Cabrera-Mu\u00f1oz","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"2019041121595831000_B292","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub","year":"2007","journal-title":"Endocr Rev"},{"issue":"4","key":"2019041121595831000_B293","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/infdis\/jiu176","article-title":"Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells","volume":"210","author":"Mitchell","year":"2014","journal-title":"J Infect Dis"},{"issue":"12","key":"2019041121595831000_B294","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm.3715","article-title":"Targeting \u03b14\u03b27 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection","volume":"20","author":"Byrareddy","year":"2014","journal-title":"Nat Med"},{"issue":"4","key":"2019041121595831000_B295","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.chom.2016.03.005","article-title":"Th17 cells are preferentially infected very early after vaginal transmission of SIV in macaques","volume":"19","author":"Stieh","year":"2016","journal-title":"Cell Host Microbe"},{"issue":"4","key":"2019041121595831000_B296","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/mi.2008.14","article-title":"Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques","volume":"1","author":"Cecchinato","year":"2008","journal-title":"Mucosal Immunol"},{"issue":"12","key":"2019041121595831000_B297","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.micinf.2013.06.012","article-title":"Progesterone suppresses Th17 cell responses, and enhances the development of regulatory T cells, through thymic stromal lymphopoietin-dependent mechanisms in experimental gonococcal genital tract infection","volume":"15","author":"Xu","year":"2013","journal-title":"Microbes Infect"},{"issue":"4","key":"2019041121595831000_B298","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000336619","article-title":"\u03b2-Defensins: multifunctional modulators of infection, inflammation and more","volume":"4","author":"Semple","year":"2012","journal-title":"J Innate Immun"},{"issue":"1","key":"2019041121595831000_B299","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-0757.2010.00373.x","article-title":"Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity","volume":"54","author":"McCormick","year":"2010","journal-title":"Periodontol 2000"},{"issue":"16","key":"2019041121595831000_B300","doi-asserted-by":"crossref","first-page":"F39","DOI":"10.1097\/00002030-200311070-00001","article-title":"Human epithelial \u03b2-defensins 2 and 3 inhibit HIV-1 replication","volume":"17","author":"Qui\u00f1ones-Mateu","year":"2003","journal-title":"AIDS"},{"issue":"1","key":"2019041121595831000_B301","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/154407370601900109","article-title":"Role of human \u03b2-defensins in HIV infection","volume":"19","author":"Weinberg","year":"2006","journal-title":"Adv Dent Res"},{"issue":"2","key":"2019041121595831000_B302","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.virol.2010.10.004","article-title":"HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells","volume":"409","author":"Tugizov","year":"2011","journal-title":"Virology"},{"issue":"6","key":"2019041121595831000_B303","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2174\/157016208786501463","article-title":"Increased levels of human \u03b2-defensins mRNA in sexually HIV-1 exposed but uninfected individuals","volume":"6","author":"Zapata","year":"2008","journal-title":"Curr HIV Res"},{"issue":"3","key":"2019041121595831000_B304","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.jid.5700599","article-title":"Antimicrobial peptides human \u03b2-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines","volume":"127","author":"Niyonsaba","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"6","key":"2019041121595831000_B305","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/art.21090","article-title":"Human \u03b2-defensin 3 mediates tissue remodeling processes in articular cartilage by increasing levels of metalloproteinases and reducing levels of their endogenous inhibitors","volume":"52","author":"Varoga","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"8","key":"2019041121595831000_B306","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.4049\/jimmunol.174.8.4870","article-title":"Differential regulation of \u03b2-defensin expression in human skin by microbial stimuli","volume":"174","author":"S\u00f8rensen","year":"2005","journal-title":"J Immunol"},{"key":"2019041121595831000_B307","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/B978-012491543-5\/50099-1","volume-title":"Mucosal Immunol.","author":"Kutteh","year":"2005","edition":"3rd ed"},{"issue":"3","key":"2019041121595831000_B308","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1365-2249.1996.36742.x","article-title":"Variations in immunoglobulins and IgA subclasses of human uterine cervical secretions around the time of ovulation","volume":"104","author":"Kutteh","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"2019041121595831000_B309","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/humupd\/dmi008","article-title":"Sex hormones and the immune response in humans","volume":"11","author":"Bouman","year":"2005","journal-title":"Hum Reprod Update"},{"issue":"3","key":"2019041121595831000_B310","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1128\/IAI.66.3.893-898.1998","article-title":"Chlamydia trachomatis infection in the female reproductive tract of the rat: influence of progesterone on infectivity and immune response","volume":"66","author":"Kaushic","year":"1998","journal-title":"Infect Immun"},{"issue":"2","key":"2019041121595831000_B311","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0165-0378(98)00086-2","article-title":"Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones","volume":"42","author":"Franklin","year":"1999","journal-title":"J Reprod Immunol"},{"issue":"1","key":"2019041121595831000_B312","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/09513590009167655","article-title":"A comparative study of the effects of two oral contraceptives containing dienogest or desogestrel on the human immune system","volume":"14","author":"Klinger","year":"2000","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"2019041121595831000_B313","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/cid\/civ298","article-title":"Genital inflammation and the risk of HIV acquisition in women","volume":"61","author":"Masson","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2019041121595831000_B314","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/COH.0000000000000232","article-title":"Genital inflammation, immune activation and risk of sexual HIV acquisition","volume":"11","author":"Passmore","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"issue":"4","key":"2019041121595831000_B315","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.contraception.2011.06.006","article-title":"Differential regulation of endogenous pro-inflammatory cytokine genes by medroxyprogesterone acetate and norethisterone acetate in cell lines of the female genital tract","volume":"84","author":"Africander","year":"2011","journal-title":"Contraception"},{"issue":"6","key":"2019041121595831000_B316","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/mi.2011.34","article-title":"Enhanced HIV-1 replication in ex vivo ectocervical tissues from post-menopausal women correlates with increased inflammatory responses","volume":"4","author":"Rollenhagen","year":"2011","journal-title":"Mucosal Immunol"},{"issue":"1","key":"2019041121595831000_B317","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0000000000000533","article-title":"Depot medroxyprogesterone acetate use is associated with elevated innate immune effector molecules in cervicovaginal secretions of HIV-1-uninfected women","volume":"69","author":"Guthrie","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"2019041121595831000_B318","first-page":"373","article-title":"Norethindrone acetate and estradiol-induced endometrial hyperplasia","volume":"96","author":"Kurman","year":"2000","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2019041121595831000_B319","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0010-7824(00)00155-4","article-title":"Effects of oral contraceptive pill use on vaginal flora and vaginal epithelium","volume":"62","author":"Eschenbach","year":"2000","journal-title":"Contraception"},{"issue":"6","key":"2019041121595831000_B320","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1600-0897.2010.00843.x","article-title":"HIV infection in the female genital tract: discrete influence of the local mucosal microenvironment","volume":"63","author":"Kaushic","year":"2010","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"2019041121595831000_B321","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1095\/biolreprod.110.090423","article-title":"Structure and function of intercellular junctions in human cervical and vaginal mucosal epithelia","volume":"85","author":"Blaskewicz","year":"2011","journal-title":"Biol Reprod"},{"issue":"4","key":"2019041121595831000_B322","first-page":"590","article-title":"Genital injury signatures and microbiome alterations associated with depot medroxyprogesterone acetate usage and intravaginal drying practices","volume":"215","author":"Birse","year":"2017","journal-title":"J Infect Dis"},{"issue":"6","key":"2019041121595831000_B323","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/mi.2013.2","article-title":"Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle","volume":"6","author":"Saba","year":"2013","journal-title":"Mucosal Immunol"},{"issue":"2","key":"2019041121595831000_B324","doi-asserted-by":"crossref","first-page":"e1006163","DOI":"10.1371\/journal.ppat.1006163","article-title":"Mucosal stromal fibroblasts markedly enhance HIV infection of CD4+ T cells","volume":"13","author":"Neidleman","year":"2017","journal-title":"PLoS Pathog"},{"issue":"17","key":"2019041121595831000_B325","doi-asserted-by":"crossref","first-page":"8793","DOI":"10.1128\/JVI.00756-15","article-title":"Molecular signatures of immune activation and epithelial barrier remodeling are enhanced during the luteal phase of the menstrual cycle: implications for HIV susceptibility","volume":"89","author":"Birse","year":"2015","journal-title":"J Virol"},{"issue":"7","key":"2019041121595831000_B326","doi-asserted-by":"crossref","first-page":"e102467","DOI":"10.1371\/journal.pone.0102467","article-title":"Free glycogen in vaginal fluids is associated with Lactobacillus colonization and low vaginal pH","volume":"9","author":"Mirmonsef","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"2019041121595831000_B327","doi-asserted-by":"crossref","first-page":"e12078","DOI":"10.1371\/journal.pone.0012078","article-title":"Deep sequencing of the vaginal microbiota of women with HIV","volume":"5","author":"Hummelen","year":"2010","journal-title":"PLoS One"},{"issue":"12\u201313","key":"2019041121595831000_B328","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.micinf.2006.08.008","article-title":"Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis","volume":"8","author":"Anukam","year":"2006","journal-title":"Microbes Infect"},{"key":"2019041121595831000_B329","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1073\/pnas.1002611107","article-title":"Vaginal microbiome of reproductive-age women","volume":"108","author":"Ravel","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"2019041121595831000_B330","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1086\/591942","article-title":"Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis","volume":"198","author":"Spear","year":"2008","journal-title":"J Infect Dis"},{"issue":"1","key":"2019041121595831000_B331","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.siny.2011.08.006","article-title":"Microbiota of the upper and lower genital tract","volume":"17","author":"Rampersaud","year":"2012","journal-title":"Semin Fetal Neonatal Med"},{"issue":"7","key":"2019041121595831000_B332","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1086\/427777","article-title":"Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women","volume":"191","author":"Watts","year":"2005","journal-title":"J Infect Dis"},{"issue":"3","key":"2019041121595831000_B333","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1086\/375819","article-title":"Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis","volume":"37","author":"Cherpes","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"8","key":"2019041121595831000_B334","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1086\/462427","article-title":"Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study","volume":"192","author":"Myer","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"2019041121595831000_B335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1086\/426394","article-title":"Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis","volume":"191","author":"Sha","year":"2005","journal-title":"J Infect Dis"},{"issue":"10","key":"2019041121595831000_B336","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1086\/429622","article-title":"Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization","volume":"40","author":"Cherpes","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2019041121595831000_B337","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/QAD.0000000000000058","article-title":"The complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota","volume":"27","author":"Achilles","year":"2013","journal-title":"AIDS"},{"issue":"6","key":"2019041121595831000_B338","doi-asserted-by":"crossref","first-page":"e1001251","DOI":"10.1371\/journal.pmed.1001251","article-title":"Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples","volume":"9","author":"Cohen","year":"2012","journal-title":"PLoS Med"},{"issue":"5","key":"2019041121595831000_B339","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.immuni.2015.04.019","article-title":"Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract","volume":"42","author":"Anahtar","year":"2015","journal-title":"Immunity"},{"issue":"3","key":"2019041121595831000_B340","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/mi.2015.86","article-title":"Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier","volume":"9","author":"Borgdorff","year":"2016","journal-title":"Mucosal Immunol"},{"issue":"9","key":"2019041121595831000_B341","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrgastro.2010.117","article-title":"Probiotics and the gut microbiota in intestinal health and disease","volume":"7","author":"Gareau","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"2019041121595831000_B342","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nri3061","article-title":"The gut microbiota: challenging immunology","volume":"11","author":"Gill","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2019041121595831000_B343","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1164\/rccm.200806-951OC","article-title":"Lactobacillus reuteri\u2013induced regulatory T cells protect against an allergic airway response in mice","volume":"179","author":"Karimi","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"2019041121595831000_B344","doi-asserted-by":"crossref","first-page":"e47556","DOI":"10.1371\/journal.pone.0047556","article-title":"A Lactobacillus rhamnosus strain induces a heme oxygenase dependent increase in Foxp3+ regulatory T cells","volume":"7","author":"Karimi","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"2019041121595831000_B345","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1600-0897.2010.00943.x","article-title":"The effects of commensal bacteria on innate immune responses in the female genital tract","volume":"65","author":"Mirmonsef","year":"2011","journal-title":"Am J Reprod Immunol"},{"issue":"5","key":"2019041121595831000_B346","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-0897.2011.01089.x","article-title":"Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with Toll-like receptor ligands","volume":"67","author":"Mirmonsef","year":"2012","journal-title":"Am J Reprod Immunol"},{"issue":"12","key":"2019041121595831000_B347","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/infdis\/jiu004","article-title":"Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner","volume":"209","author":"Doerflinger","year":"2014","journal-title":"J Infect Dis"},{"issue":"5","key":"2019041121595831000_B348","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/QAI.0b013e318189a7ca","article-title":"Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment","volume":"49","author":"Rebbapragada","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"2019041121595831000_B349","doi-asserted-by":"crossref","first-page":"e73055","DOI":"10.1371\/journal.pone.0073055","article-title":"Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis","volume":"8","author":"Vodstrcil","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"2019041121595831000_B350","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/OLQ.0000000000000245","article-title":"The impact of hormonal contraception and pregnancy on sexually transmitted infections and on cervicovaginal microbiota in african sex workers","volume":"42","author":"Borgdorff","year":"2015","journal-title":"Sex Transm Dis"},{"issue":"1","key":"2019041121595831000_B351","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10096-016-2768-8","article-title":"Influence of contraceptive choice on vaginal bacterial and fungal microflora","volume":"36","author":"Donders","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"2019041121595831000_B352","doi-asserted-by":"crossref","first-page":"1303265","DOI":"10.1080\/16512235.2017.1303265","article-title":"Changes in vaginal community state types reflect major shifts in the microbiome","volume":"28","author":"Brooks","year":"2017","journal-title":"Microb Ecol Health Dis"},{"issue":"4","key":"2019041121595831000_B353","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.contraception.2016.11.006","article-title":"Effects of combined oral contraceptives, depot medroxyprogesterone acetate and the levonorgestrel-releasing intrauterine system on the vaginal microbiome","volume":"95","author":"Brooks","year":"2017","journal-title":"Contraception"},{"issue":"5","key":"2019041121595831000_B354","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.contraception.2012.02.012","article-title":"Effects of hormonal contraception on vaginal flora","volume":"86","author":"De Seta","year":"2012","journal-title":"Contraception"},{"key":"2019041121595831000_B355","first-page":"A217","article-title":"P3.221\u2005Oral and injectable hormonal contraception decrease risk of bacterial vaginosis but oral contraception may increase risk of vaginal candidiasis: a systematic review of published and unpublished data","volume-title":"Sex Transm Infect","author":"van de Wijgert","year":"2013"},{"issue":"6","key":"2019041121595831000_B356","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.contraception.2012.05.148","article-title":"Effect of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) on serum androgen markers in normal-weight, obese, and extremely obese women","volume":"86","author":"Segall-Gutierrez","year":"2012","journal-title":"Contraception"},{"issue":"3","key":"2019041121595831000_B357","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2265.2007.03059.x","article-title":"Effect of progestins with different glucocorticoid activity on bone metabolism","volume":"68","author":"Ishida","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2019041121595831000_B358","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0010-7824(93)90001-N","article-title":"What we have learned from recent IUD studies: a researcher\u2019s perspective","volume":"48","author":"Chi","year":"1993","journal-title":"Contraception"},{"issue":"1","key":"2019041121595831000_B359","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0010-7824(87)90057-6","article-title":"Endometrial morphological changes in IUD users: a review","volume":"36","author":"Sheppard","year":"1987","journal-title":"Contraception"},{"issue":"2","key":"2019041121595831000_B360","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0010-7824(02)00331-1","article-title":"Cervical mucus granulocyte macrophage colony stimulating factor and interleukin-2 soluble receptor in women using copper intrauterine contraceptive devices","volume":"66","author":"Shobokshi","year":"2002","journal-title":"Contraception"},{"issue":"4","key":"2019041121595831000_B361","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0015-0282(16)57480-9","article-title":"Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium","volume":"63","author":"Amm\u00e4l\u00e4","year":"1995","journal-title":"Fertil Steril"},{"issue":"4","key":"2019041121595831000_B362","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000291972","article-title":"Raised circulating levels of interleukin-6 in women with an intrauterine contraceptive device","volume":"42","author":"Woolley","year":"1996","journal-title":"Gynecol Obstet Invest"},{"issue":"6","key":"2019041121595831000_B363","doi-asserted-by":"crossref","first-page":"e38100","DOI":"10.1371\/journal.pone.0038100","article-title":"Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract","volume":"7","author":"Lahey","year":"2012","journal-title":"PLoS One"},{"key":"2019041121595831000_B364","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1097\/01.qai.0000167030.18278.0e","article-title":"Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort","volume":"38","author":"Baeten","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"2019041121595831000_B365","doi-asserted-by":"crossref","first-page":"144.e1","DOI":"10.1016\/j.ajog.2007.03.031","article-title":"A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus","volume":"197","author":"Stringer","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"5265","key":"2019041121595831000_B366","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1126\/science.272.5265.1167","article-title":"Prognosis in HIV-1 infection predicted by the quantity of virus in plasma","volume":"272","author":"Mellors","year":"1996","journal-title":"Science"},{"issue":"9","key":"2019041121595831000_B367","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/503258","article-title":"Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women","volume":"42","author":"Lavreys","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2019041121595831000_B368","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/QAD.0b013e32832cbca8","article-title":"HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial","volume":"23","author":"Stringer","year":"2009","journal-title":"AIDS"},{"issue":"11","key":"2019041121595831000_B369","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/00002030-200307250-00019","article-title":"Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women","volume":"17","author":"Cejtin","year":"2003","journal-title":"AIDS"},{"issue":"9082","key":"2019041121595831000_B370","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0140-6736(97)04240-2","article-title":"Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina","volume":"350","author":"Mostad","year":"1997","journal-title":"Lancet"},{"issue":"1","key":"2019041121595831000_B371","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2015.10.002","article-title":"The safety of hormonal contraceptives for women living with HIV and their sexual partners","volume":"93","author":"Phillips","year":"2016","journal-title":"Contraception"},{"issue":"4","key":"2019041121595831000_B372","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QAD.0b013e32835ad539","article-title":"Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence","volume":"27","author":"Polis","year":"2013","journal-title":"AIDS"},{"issue":"5","key":"2019041121595831000_B373","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/QAD.0b013e32835bb672","article-title":"Effect of hormonal contraceptive methods on HIV disease progression: a systematic review","volume":"27","author":"Phillips","year":"2013","journal-title":"AIDS"},{"issue":"4","key":"2019041121595831000_B374","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1128\/CMR.14.4.753-777.2001","article-title":"Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection","volume":"14","author":"Lawn","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"2019041121595831000_B375","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00002030-200401230-00009","article-title":"The effect of hormonal contraception on genital tract shedding of HIV-1","volume":"18","author":"Wang","year":"2004","journal-title":"AIDS"},{"issue":"22","key":"2019041121595831000_B376","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1001\/jama.1993.03500220046024","article-title":"Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya","volume":"269","author":"Clemetson","year":"1993","journal-title":"JAMA"},{"issue":"1","key":"2019041121595831000_B377","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(11)70247-X","article-title":"Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study","volume":"12","author":"Heffron","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"2019041121595831000_B378","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1473-3099(12)70115-9","article-title":"Use of hormonal contraceptives and risk of HIV-1 transmission","volume":"12","author":"Gisselquist","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"2019041121595831000_B379","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.contraception.2012.03.008","article-title":"Hormonal contraception and HIV acquisition risk: implications for individual users and public policies","volume":"86","author":"Jain","year":"2012","journal-title":"Contraception"},{"issue":"9","key":"2019041121595831000_B380","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1471-0528.2012.03402.x","article-title":"Evaluating the competing risks of HIV acquisition and maternal mortality in Africa: a decision analysis","volume":"119","author":"Rodriguez","year":"2012","journal-title":"BJOG"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/39\/1\/36\/23792781\/er.2017-00103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T17:08:19Z","timestamp":1660237699000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/39\/1\/36\/4788769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,4]]},"references-count":380,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,4]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2017-00103","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2018,1,4]]}}}